Search

everythinglearnresearchcommunity

for

Search:↓

Tadalafil may reduce the risk of major heart events and blood clots in men with urinary symptoms.

The combination of tadalafil and finasteride improves urinary symptoms and erectile function in men with enlarged prostates.

5-Alpha reductase inhibitors help treat enlarged prostate but may cause sexual side effects.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

A new drug, dutasteride, is at least as effective as the older drug, finasteride, for treating enlarged prostate and may have additional uses.

Persistent ED in Propecia users is not due to abnormal blood flow.

Long-term use of certain prostate drugs can worsen erectile dysfunction by changing penile tissue, especially in rats with high blood pressure.

Dutasteride use can lead to a stable decline in sexual function that is not affected by age or prostate size.

Dutasteride is more effective than finasteride for treating BPH without extra safety risks.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

Certain medications, especially 5-alpha reductase inhibitors, are commonly linked to erectile dysfunction.

Finasteride is a safe and effective long-term treatment for prostate enlargement, reducing prostate volume and related symptoms.

Combining α1-blockers with 5α-reductase inhibitors improves urinary symptoms in men.

5α-reductase inhibitors, like Finasteride and Dutasteride, help manage benign prostatic hyperplasia.

Combining dutasteride or finasteride with an α1 blocker is more effective for managing BPH than using either alone.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

Dutasteride effectively treats enlarged prostate with manageable side effects.

5-alpha-reductase inhibitors can effectively treat benign prostatic hyperplasia.

Five-alpha reductase inhibitors, like finasteride and dutasteride, can treat enlarged prostates, improve urination, reduce need for prostate surgery, and lower the risk of prostate cancer, but may increase the risk of higher grade prostate cancer. They can also treat male pattern baldness.

Regulatory challenges make developing combination therapies in urology difficult and costly.

5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction, but the exact reasons are unclear.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

Dutasteride and finasteride don't raise erectile dysfunction risk.

Using hair loss drugs finasteride and dutasteride may cause sexual side effects.

Taking 5-α reductase inhibitors for prostate enlargement or hair loss does not significantly raise the risk of erectile dysfunction.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

Certain drugs that block specific enzymes can help treat prostate diseases.

Finasteride helps improve treatment for benign prostatic hyperplasia.